HTA Around the World


HTA Around the World: Broadening Our Understanding of Cross-Country Differences

The Emerging Social Science Literature on Health Technology Assessment: A Narrative Review

Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations

Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis

Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?

Increasing the Legitimacy of Tough Choices in Healthcare Reimbursement: Approach and Results of a Citizen Forum in The Netherlands

Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary

Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System

 

Value-Based Contracting


Is There a Future for Value-Based Contracting?

Are Value-Based Arrangements the Answer We’ve Been Waiting for?

Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead

Managed Entry Agreements: Policy Analysis From the European Perspective

Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications

 

Precision Medicine


Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy

Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group

Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions

Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019

Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing

 

Applications of Health Preferences Research


Science or Art? Reproducibility of Health Preference Research

Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions—Report of the ISPOR Stated Preference Research Special Interest Group

Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment

Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment

Patient Preferences in the Treatment of Hemophilia A: A Best–Worst Scaling Case 3 Analysis

The Preferred Qualities of Human Immunodeficiency Virus Testing and Self-Testing Among Men Who Have Sex With Men: A Discrete Choice Experiment

Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments

 

COVID-19


The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)

Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China

Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations

Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group

The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease–2019 Treatments Available and Affordable

Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom

Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study



Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×